Estimating the Effect of a Low Nicotine Standard on Smoking Behavior in the U.S. Population
Abstract
In January of 2025, the FDA announced a proposed rule to set a nationwide nicotine standard of 0.7 mg/cigarette that would reduce nicotine levels in cigarettes by 95%. Past trials comparing very-low nicotine content (VLNC) cigarettes and normal nicotine content (NNC) cigarettes consistently found randomization to receive VLNC cigarettes reduces cigarette consumption. However, these results are not intrinsically generalizable, as the trials exhibited partial treatment non-adherence and were not designed as representative samples of the United States (U.S.) population of people who smoke (PWS). Existing transportability methods do not account for non-adherence or target a different estimand. Additionally, non-adherence cannot be directly observed and must be estimated using biomarkers of nicotine exposure, and different biomarkers were collected across trials. To estimate the effect of full adherence to a low nicotine standard in the U.S. population of PWS, we develop a novel inverse odds weighting estimator for transporting an intervention's effect to a fully adherent target population, and propose a bivariate mixture model approach for estimating adherence using biomarkers that allows partial missingness in one of the biomarkers. Finally, we use our method to transport inferences from seven trials investigating VLNC cigarettes to a representative sample of U.S. PWS.
Related
- Coarsened Data in Small Area Estimation: A Bayesian Two-Part Model for Mapping Smoking Behavior.
- Estimating Population-Risk Curves Along Nonconvex Gradient Flows from the Training Sample
- Where to weight? Estimating population causal effects with weighted double score matching in complex surveys
- Estimating the hyperuniformity exponent of spatial point processes
- Approaches and challenges in estimating economic loss from tsunami damage models
BibTeX
@misc{silva2026estimating,
title = {{Estimating the Effect of a Low Nicotine Standard on Smoking Behavior in the U.S. Population}},
author = {Milena I. Silva and Lianne K. Siegel and Katherine J. Li and David M. Vock and Eric C. Donny and Dorothy K. Hatsukami and Stephen T. Higgins and Jennifer W. Tidey and Sarah H. Heil and Stacey C. Sigmon and Joseph S. Koopmeiners and Jared D. Huling},
howpublished = {arXiv},
year = {2026},
month = oct,
doi = {10.48550/arxiv.2610.36324},
eprint = {2610.36324},
archivePrefix = {arXiv},
url = {https://arxiv.org/abs/2610.36324},
note = {CC BY 4.0},
}
RIS
TY - UNPB
TI - Estimating the Effect of a Low Nicotine Standard on Smoking Behavior in the U.S. Population
AU - Milena I. Silva
AU - Lianne K. Siegel
AU - Katherine J. Li
AU - David M. Vock
AU - Eric C. Donny
AU - Dorothy K. Hatsukami
AU - Stephen T. Higgins
AU - Jennifer W. Tidey
AU - Sarah H. Heil
AU - Stacey C. Sigmon
AU - Joseph S. Koopmeiners
AU - Jared D. Huling
PY - 2026
DA - 2026/10/26
PB - arXiv
DO - 10.48550/arxiv.2610.36324
UR - https://arxiv.org/abs/2610.36324
AB - In January of 2025, the FDA announced a proposed rule to set a nationwide nicotine standard of 0.7 mg/cigarette that would reduce nicotine levels in cigarettes by 95%. Past trials comparing very-low nicotine content (VLNC) cigarettes and normal nicotine content (NNC) cigarettes consistently found randomization to receive VLNC cigarettes reduces cigarette consumption. However, these results are not intrinsically generalizable, as the trials exhibited partial treatment non-adherence and were not designed as representative samples of the United States (U.S.) population of people who smoke (PWS). Existing transportability methods do not account for non-adherence or target a different estimand. Additionally, non-adherence cannot be directly observed and must be estimated using biomarkers of nicotine exposure, and different biomarkers were collected across trials. To estimate the effect of full adherence to a low nicotine standard in the U.S. population of PWS, we develop a novel inverse odds weighting estimator for transporting an intervention's effect to a fully adherent target population, and propose a bivariate mixture model approach for estimating adherence using biomarkers that allows partial missingness in one of the biomarkers. Finally, we use our method to transport inferences from seven trials investigating VLNC cigarettes to a representative sample of U.S. PWS.
ER -